Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis.

MLA

Robin, Marie, et al. “Long-Term Outcome after Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis.” Haematologica, vol. 104, no. 9, Sept. 2019, pp. 1782–88. EBSCOhost, https://doi.org/10.3324/haematol.2018.205211.

APA

Robin, M., de Wreede, L. C., Wolschke, C., Schetelig, J., Eikema, D.-J., Van Lint, M. T., Knelange, N. S., Beelen, D., Brecht, A., Niederwieser, D., Vitek, A., Bethge, W., Arnold, R., Finke, J., Volin, L., Yakoub-Agha, I., Nagler, A., Poiré, X., Einsele, H., … Kröger, N. (2019). Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis. Haematologica, 104(9), 1782–1788. https://doi.org/10.3324/haematol.2018.205211

Chicago

Robin, Marie, Liesbeth C de Wreede, Christine Wolschke, Johannes Schetelig, Diderik-Jan Eikema, Maria Teresa Van Lint, Nina Simone Knelange, et al. 2019. “Long-Term Outcome after Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis.” Haematologica 104 (9): 1782–88. doi:10.3324/haematol.2018.205211.